Trials / Completed
CompletedNCT02232750
Evaluation of CPD MNV as an Aid in the Diagnosis and Risk Assessment of Sepsis (Protocol # Sepsis 1-14)
Evaluation of CPD (Cell Population Data) MNV (Mean Neutrophil Volume) as an Aid in the Diagnosis and Risk Assessment of Sepsis (Protocol # Sepsis 1-14)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,320 (actual)
- Sponsor
- Ohio State University · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Accepted
Summary
The investigators hypothesize that CPD parameters will provide improved prediction of sepsis compared to currently employed laboratory parameters. These studies hold the potential to shape practitioner guidelines and improve the timeliness and accuracy with which patients with sepsis are treated today.
Conditions
Timeline
- Start date
- 2014-07-14
- Primary completion
- 2015-08-15
- Completion
- 2015-08-15
- First posted
- 2014-09-05
- Last updated
- 2021-11-03
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02232750. Inclusion in this directory is not an endorsement.